GeneType and Humanise Health host “Know Your Risk” Event
May 23, 2024 08:00 ET
|
Genetic Technologies Ltd
"Know Your Risk" Event a remarkable success in Pasadena.
Bion Gives Company Update
May 22, 2024 10:55 ET
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, May 22, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef, gave the...
CryoMass Partners with Cannabis Powerhouse LEEF to Deploy Its Cryo Separation Technology
May 16, 2024 07:10 ET
|
Cryomass Technologies
CryoMass announced the sale of its second CryoSift Separator™ production model for US$1.2 million.
CryoMass Announces Sale of First Production Model to be deployed in Canada
May 14, 2024 07:10 ET
|
Cryomass Technologies
The transaction we are announcing today is the first of such Unit sales for CAD$1.62 million, which will be deployed in Canada.
GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employees
May 06, 2024 08:00 ET
|
Genetic Technologies Ltd
Genetic Technologies and 'Wellworks for You' sign B2B sales and marketing deal covering 750 employer groups and 2 million U.S. employees
Appendix 4C & Quarterly Business Update – March 2024
April 30, 2024 08:00 ET
|
Genetic Technologies Ltd
Quarterly Business Update; Launching our most comprehensive test and expanding into new global markets
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024
April 24, 2024 22:11 ET
|
Association québécoise des technologies (AQT)
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024Charlevoix (Québec), le 24 avril 2024 – C’est avec fierté que l’AQT
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
April 22, 2024 15:00 ET
|
Genetic Technologies Ltd
Genetic Technologies Announces Closing of $2 Million Registered Direct Offering
Leber Congenital Amaurosis Pipeline Insight 2024, Featuring Key Players ProQR Therapeutics, Editas Medicine, Atsena Therapeutics, Applied Genetic Technologies, IVERIC bio and MeiraGTx
April 22, 2024 07:51 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Leber congenital amaurosis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides...
Genetic Technologies Announces $2 Million Registered Direct Offering
April 18, 2024 12:17 ET
|
Genetic Technologies Ltd
Genetic Technologies Announces $2 Million Registered Direct Offering